| Trial ID: | L0330 |
| Source ID: | NCT04559126
|
| Associated Drug: |
EDP-297
|
| Title: |
A Study of EDP-297 in Healthy Subjects
|
| Acronym: |
--
|
| Status: |
Completed
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
NASH - Nonalcoholic Steatohepatitis With Liver Fibrosis
|
| Interventions: |
Drug: EDP-297|Drug: Placebo
|
| Outcome Measures: |
Safety measured by adverse events|Cmax of EDP-297|AUC of EDP-297
|
| Sponsor/Collaborators: |
Enanta Pharmaceuticals|PRA Health Sciences
|
| Gender: |
All
|
| Age: |
18 Years to 65 Years ?? (Adult, Older Adult)
|
| Phases: |
Phase 1
|
| Enrollment: |
82
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment
|
| Start Date: |
September 8, 2020
|
| Completion Date: |
June 21, 2021
|
| Results First Posted: |
--
|
| Last Update Posted: |
October 29, 2021
|
| Locations: |
PRA Health Sciences, Groningen, Netherlands
|
| URL: |
https://ClinicalTrials.gov/show/NCT04559126
|
